USD 3.02
(-0.33%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -39.31 Million CAD | 44.52% |
2022 | -70.84 Million CAD | -102.21% |
2021 | -35.03 Million CAD | -451.42% |
2020 | -6.35 Million CAD | 75.83% |
2019 | -26.29 Million CAD | -480.07% |
2018 | -4.53 Million CAD | -1629.63% |
2017 | 296.31 Thousand CAD | -75.63% |
2016 | 1.21 Million CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -25 Thousand CAD | 92.65% |
2024 Q3 | 717 Thousand CAD | 2968.0% |
2024 Q1 | -340 Thousand CAD | 98.9% |
2023 Q3 | -2.86 Million CAD | -82.65% |
2023 Q4 | -30.78 Million CAD | -975.0% |
2023 FY | -39.31 Million CAD | 44.52% |
2023 Q2 | -1.56 Million CAD | 59.4% |
2023 Q1 | -3.86 Million CAD | 92.64% |
2022 Q2 | -8.27 Million CAD | -5.71% |
2022 FY | -70.84 Million CAD | -102.21% |
2022 Q4 | -52.5 Million CAD | -1832.35% |
2022 Q3 | -2.71 Million CAD | 67.17% |
2022 Q1 | -7.83 Million CAD | -60.52% |
2021 Q4 | -4.87 Million CAD | -168.17% |
2021 FY | -35.03 Million CAD | -451.42% |
2021 Q1 | -16.86 Million CAD | -873.96% |
2021 Q2 | -12.33 Million CAD | 26.9% |
2021 Q3 | -1.81 Million CAD | 85.25% |
2020 Q3 | 4.26 Million CAD | 184.58% |
2020 Q4 | -1.73 Million CAD | -140.58% |
2020 FY | -6.35 Million CAD | 75.83% |
2020 Q1 | -3.84 Million CAD | 74.98% |
2020 Q2 | -5.04 Million CAD | -31.27% |
2019 Q1 | -3.82 Million CAD | 0.88% |
2019 FY | -26.29 Million CAD | -480.07% |
2019 Q4 | -15.36 Million CAD | -315.69% |
2019 Q3 | -3.69 Million CAD | -11.36% |
2019 Q2 | -3.31 Million CAD | 13.15% |
2018 Q2 | -396 Thousand CAD | -221.66% |
2018 Q4 | -3.85 Million CAD | -537.28% |
2018 FY | -4.53 Million CAD | -1629.63% |
2018 Q1 | 325.49 Thousand CAD | 218.19% |
2018 Q3 | -605 Thousand CAD | -52.78% |
2017 Q3 | 571.35 Thousand CAD | 0.0% |
2017 Q4 | -275.41 Thousand CAD | -148.2% |
2017 FY | 296.31 Thousand CAD | -75.63% |
2016 FY | 1.21 Million CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -19.93 Million USD | -97.19% |
BIMI International Medical Inc. | -22.35 Million USD | -75.862% |
China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -828.386% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | -61.034% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | -61.034% |
Leafly Holdings, Inc. | -9.49 Million USD | -313.877% |
Leafly Holdings, Inc. | -9.49 Million USD | -313.877% |
LifeMD, Inc. | -20.59 Million USD | -90.862% |
LifeMD, Inc. | -20.59 Million USD | -90.862% |
TRxADE HEALTH, Inc. | -17.84 Million USD | -120.303% |
PetMed Express, Inc. | -7.46 Million USD | -426.661% |
Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.545% |